A detailed history of Montag A & Associates Inc transactions in Viatris Inc stock. As of the latest transaction made, Montag A & Associates Inc holds 401 shares of VTRS stock, worth $4,972. This represents 0.0% of its overall portfolio holdings.

Number of Shares
401
Previous 401 -0.0%
Holding current value
$4,972
Previous $4,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 31, 2024

SELL
$10.05 - $12.02 $1,819 - $2,175
-181 Reduced 31.1%
401 $4,000
Q4 2023

Feb 07, 2024

SELL
$8.77 - $10.85 $1,508 - $1,866
-172 Reduced 22.81%
582 $6,000
Q3 2023

Nov 09, 2023

SELL
$9.59 - $11.35 $1,189 - $1,407
-124 Reduced 14.12%
754 $7,000
Q1 2023

May 11, 2023

SELL
$9.2 - $12.26 $41,206 - $54,912
-4,479 Reduced 83.61%
878 $8,000
Q4 2022

Feb 02, 2023

SELL
$8.72 - $11.56 $2,659 - $3,525
-305 Reduced 5.39%
5,357 $59,000
Q3 2022

Nov 09, 2022

SELL
$8.48 - $11.13 $3,035 - $3,984
-358 Reduced 5.95%
5,662 $48,000
Q2 2022

Aug 10, 2022

SELL
$9.95 - $12.27 $7,770 - $9,582
-781 Reduced 11.48%
6,020 $63,000
Q4 2021

Feb 09, 2022

SELL
$12.09 - $14.68 $18,848 - $22,886
-1,559 Reduced 18.65%
6,801 $92,000
Q3 2021

Nov 08, 2021

SELL
$13.25 - $15.13 $23,532 - $26,870
-1,776 Reduced 17.52%
8,360 $113,000
Q2 2021

Aug 03, 2021

SELL
$12.97 - $16.15 $10,752 - $13,388
-829 Reduced 7.56%
10,136 $145,000
Q1 2021

May 14, 2021

SELL
$13.59 - $18.54 $74,812 - $102,062
-5,505 Reduced 33.42%
10,965 $153,000
Q4 2020

Feb 12, 2021

BUY
$14.3 - $18.74 $235,521 - $308,647
16,470 New
16,470 $309,000

Others Institutions Holding VTRS

About Viatris Inc


  • Ticker VTRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,212,669,952
  • Market Cap $15B
  • Description
  • Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...
More about VTRS
Track This Portfolio

Track Montag A & Associates Inc Portfolio

Follow Montag A & Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Montag A & Associates Inc, based on Form 13F filings with the SEC.

News

Stay updated on Montag A & Associates Inc with notifications on news.